Mr. Antal Rohit Desai - Director, 10%+ Owner at REATA PHARMACEUTICALS INC

Issuer-level insider activity

Role: Director, 10%+ Owner
Issuer ticker: RETA
Entity type: Individual
Source filing history: Open source filing history

No buys or sells have been reported by Mr. Antal Rohit Desai since 21 Oct 2025

Reported holdings for Mr. Antal Rohit Desai in REATA PHARMACEUTICALS INC

Form 4 holding Director, 10%+ Owner

REATA PHARMACEUTICALS INC

Security class: Class A common stock
Shares / value: 0
Estimated value
Report date: 26 Sep 2023
Price: $172.03
Ownership: By Barred Owl Partners, LP

Form 4 holding Director, 10%+ Owner

REATA PHARMACEUTICALS INC

Security class: Class A common stock
Shares / value: 0
Estimated value
Report date: 26 Sep 2023
Price: $172.03
Ownership: By CD Fund, LP

Form 4 holding Director, 10%+ Owner

REATA PHARMACEUTICALS INC

Security class: Class A common stock
Shares / value: 0
Estimated value
Report date: 26 Sep 2023
Price: $172.03
Ownership: By CPMG, Inc.

Form 4 holding Director, 10%+ Owner

REATA PHARMACEUTICALS INC

Security class: Class A common stock
Shares / value: 0
Estimated value
Report date: 26 Sep 2023
Price: $172.03
Ownership: By Crested Crane, LP

Form 4 holding Director, 10%+ Owner

REATA PHARMACEUTICALS INC

Security class: Class A common stock
Shares / value: 0
Estimated value
Report date: 26 Sep 2023
Price: $172.03
Ownership: By Elepaio Partners, LP

Form 4 holding Director, 10%+ Owner

REATA PHARMACEUTICALS INC

Security class: Class A common stock
Shares / value: 0
Estimated value
Report date: 26 Sep 2023
Price: $172.03
Ownership: By Gallopavo, LP

Form 4 holding Director, 10%+ Owner

REATA PHARMACEUTICALS INC

Security class: Class A common stock
Shares / value: 0
Estimated value
Report date: 26 Sep 2023
Price: $172.03
Ownership: By Kestrel Fund, LP(

Form 4 holding Director, 10%+ Owner

REATA PHARMACEUTICALS INC

Security class: Class A common stock
Shares / value: 0
Estimated value
Report date: 26 Sep 2023
Price: $172.03
Ownership: By Killdeer Fund, LP

Form 4 holding Director, 10%+ Owner

REATA PHARMACEUTICALS INC

Security class: Class A common stock
Shares / value: 0
Estimated value
Report date: 26 Sep 2023
Price: $172.03
Ownership: By Mallard Fund, LP

Form 4 holding Director, 10%+ Owner

REATA PHARMACEUTICALS INC

Security class: Class A common stock
Shares / value: 0
Estimated value
Report date: 26 Sep 2023
Price: $172.03
Ownership: By Managed Account for Trustees of the University of Pennsylvania

Form 4 holding Director, 10%+ Owner

REATA PHARMACEUTICALS INC

Security class: Class A common stock
Shares / value: 0
Estimated value
Report date: 26 Sep 2023
Price: $172.03
Ownership: By Nighthawk Partners, LP

Form 4 holding Director, 10%+ Owner

REATA PHARMACEUTICALS INC

Security class: Class A common stock
Shares / value: 0
Estimated value
Report date: 26 Sep 2023
Price: $172.03
Ownership: By Redbird Life Sciences Partners, LP

Form 4 holding Director, 10%+ Owner

REATA PHARMACEUTICALS INC

Security class: Class A common stock
Shares / value: 0
Estimated value
Report date: 26 Sep 2023
Price: $172.03
Ownership: By Roadrunner Fund, LP

Form 4 holding Director, 10%+ Owner

REATA PHARMACEUTICALS INC

Security class: Class A common stock
Shares / value: 0
Estimated value
Report date: 26 Sep 2023
Price: $172.03
Ownership: By Sandpiper Fund, LP

Form 4 holding Director, 10%+ Owner

REATA PHARMACEUTICALS INC

Security class: Class A common stock
Shares / value: 0
Estimated value
Report date: 26 Sep 2023
Price: $172.03
Ownership: By The 2:22 DNA Trust

Form 4 holding Director, 10%+ Owner

REATA PHARMACEUTICALS INC

Security class: Class A common stock
Shares / value: 0
Estimated value
Report date: 26 Sep 2023
Price: $172.03
Ownership: By Willet Fund, LP

Form 4 holding Director, 10%+ Owner

REATA PHARMACEUTICALS INC

Security class: Class A common stock
Shares / value: 0
Estimated value
Report date: 26 Sep 2023
Price: $172.03
Ownership: By Yellow Warbler, LP

Form 4 holding Director, 10%+ Owner

REATA PHARMACEUTICALS INC

Security class: Class B common stock
Shares / value: 0
Estimated value
Report date: 26 Sep 2023
Price: $172.03
Ownership: By CD Fund, LP
Underlying class: Class A common stock
Underlying amount

Form 4 holding Director, 10%+ Owner

REATA PHARMACEUTICALS INC

Security class: Class B common stock
Shares / value: 0
Estimated value
Report date: 26 Sep 2023
Price: $172.03
Ownership: By CPMG, Inc.
Underlying class: Class A common stock
Underlying amount

Form 4 holding Director, 10%+ Owner

REATA PHARMACEUTICALS INC

Security class: Class B common stock
Shares / value: 0
Estimated value
Report date: 26 Sep 2023
Price: $172.03
Ownership: By Kestrel Fund, LP
Underlying class: Class A common stock
Underlying amount

Form 4 holding Director, 10%+ Owner

REATA PHARMACEUTICALS INC

Security class: Class B common stock
Shares / value: 0
Estimated value
Report date: 26 Sep 2023
Price: $172.03
Ownership: By Mallard Fund, LP
Underlying class: Class A common stock
Underlying amount

Form 4 holding Director, 10%+ Owner

REATA PHARMACEUTICALS INC

Security class: Class B common stock
Shares / value: 0
Estimated value
Report date: 26 Sep 2023
Price: $172.03
Ownership: By Redbird Life Sciences Partners, LP
Underlying class: Class A common stock
Underlying amount

Form 4 holding Director, 10%+ Owner

REATA PHARMACEUTICALS INC

Security class: Class B common stock
Shares / value: 0
Estimated value
Report date: 26 Sep 2023
Price: $172.03
Ownership: By Willet Fund, LP
Underlying class: Class A common stock
Underlying amount

Form 4 holding Director, 10%+ Owner

REATA PHARMACEUTICALS INC

Security class: Class B common stock
Shares / value: 0
Estimated value
Report date: 26 Sep 2023
Price: $172.03
Ownership: By Yellow Warbler, LP
Underlying class: Class A common stock
Underlying amount

Transaction history for Mr. Antal Rohit Desai in REATA PHARMACEUTICALS INC

Sym	Class	Transaction	%	SEC-reported value	SEC-reported price	Shares	Shares after	Date	Ownership

^* marks a reported price that did not pass the local price check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .